Search - tctmd.com

Displaying 121 - 140 of 465

Sort: Relevancy | Date

Presentation TCT 2022

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Presenter: David Kandzari

September 17, 2022

Presentation TCT 2022

TCT 215: Association between Renal Sympathetic Denervation and Arterial Stiffness: the ASORAS Study.

Presenter: Victor Zeijen

September 17, 2022

Presentation TCT 2022

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

Presenter: Horst Sievert

September 17, 2022

Presentation TCT 2022

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

Presenter: Roland Schmieder

September 17, 2022

Presentation

TCT 211: Home Blood Pressure Response to Ultrasound Renal Denervation - a Patient-level Pooled Analysis of the RADIANCE-HTN SOLO and TRIO Randomised, Sham-controlled Trials

Presenter: Andrew Sharp

September 17, 2022

Presentation TCT 2022

TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study

Presenter: Daniel Burkhoff

September 17, 2022

Presentation TCT 2022

TCT 210: Long-term blood pressure results after renal sympathetic denervation using endovascular ultrasound

Presenter: Karl Fengler

September 17, 2022

Presentation EuroPCR 2022

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Presenter: Felix Mahfoud

May 20, 2022

Presentation ARCH 2022

Current Status and Future of Renal Denervation for Hypertension

Presenter: Tim A. Fischell

April 23, 2022

Presentation ACC 2022

Long Term Efficacy and Safety of Renal Denervation on Blood Pressure in Patients on Antihypertension Medications: 3-Year Outcomes from the SPYRAL HTN-ON MED Trial

Presenter: Felix Mahfoud

April 04, 2022

Presentation TCT 2021

Leading with Evidence: Latest Data on Renal Denervation

Presenter: NULL

November 06, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

Presentation TCT 2021

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

Presenter: Ajay Kirtane

November 04, 2021

Presentation TCT 2021

TCT 677: Renal denervation in a young patient with malignant hypertension

Presenter: Maria Antonieta Lopes

November 04, 2021

Presentation TCT 2021

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

Presenter: Mikhail Tarasov

November 04, 2021

Presentation ACC 2021

Ultrasound Renal Denervation for Hypertension Resistant to a Triple Medication Pill: The Randomized Sham Controlled RADIANCE-HTN TRIO Trial

Presenter: Ajay J. Kirtane

May 16, 2021

Presentation TCT 2020

Anatomy of Human Accessory Renal Artery Peri-Arterial Renal Sympathetic Nerve for Renal Denervation

Presenter: Yu Sato

October 18, 2020

Presentation TCT 2020

Anatomy of Human Accessory Renal Artery Peri-Arterial Renal Sympathetic Nerve for Renal Denervation

Presenter: Yu Sato

October 18, 2020

Presentation TCT 2020

I Recommend Renal Denervation!

Presenter: Andrew Sharp

October 17, 2020

Presentation TCT 2020

TCT 422: Effect of Sympathetic Renal Denervation on Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis

Presenter: Syed Mustafa

October 14, 2020

Advertisement

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

TCT 215: Association between Renal Sympathetic Denervation and Arterial Stiffness: the ASORAS Study.

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial

TCT 211: Home Blood Pressure Response to Ultrasound Renal Denervation - a Patient-level Pooled Analysis of the RADIANCE-HTN SOLO and TRIO Randomised, Sham-controlled Trials

TCT 213: Impact of Cardiac Neuromodulation Therapy (CNT) on Systolic Blood Pressure and Pulse Pressure in Hypertensive Patients Indicated for a Pacemaker: Results of a Crossover Study

TCT 210: Long-term blood pressure results after renal sympathetic denervation using endovascular ultrasound

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Current Status and Future of Renal Denervation for Hypertension

Long Term Efficacy and Safety of Renal Denervation on Blood Pressure in Patients on Antihypertension Medications: 3-Year Outcomes from the SPYRAL HTN-ON MED Trial

Leading with Evidence: Latest Data on Renal Denervation

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

TCT 677: Renal denervation in a young patient with malignant hypertension

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

Ultrasound Renal Denervation for Hypertension Resistant to a Triple Medication Pill: The Randomized Sham Controlled RADIANCE-HTN TRIO Trial

Anatomy of Human Accessory Renal Artery Peri-Arterial Renal Sympathetic Nerve for Renal Denervation

Anatomy of Human Accessory Renal Artery Peri-Arterial Renal Sympathetic Nerve for Renal Denervation

I Recommend Renal Denervation!

TCT 422: Effect of Sympathetic Renal Denervation on Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content